Amylyx Pharmaceuticals shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Amylyx Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Amylyx Pharmaceuticals held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Amylyx Pharmaceuticals by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $79k | 5.8k | 13.59 |
| 2025-06-30 | $45k | 7.1k | 6.41 |
| 2024-03-31 | $14k | 5.0k | 2.84 |
| 2023-12-31 | $74k | 5.0k | 14.72 |
| 2023-09-30 | $92k | 5.0k | 18.31 |
| 2023-06-30 | $87k | 4.0k | 21.57 |
| 2023-03-31 | $118k | 4.0k | 29.34 |
| 2022-12-31 | $153k | 4.0k | 37.90 |
| 2022-09-30 | $77k | 2.8k | 27.86 |
| 2022-06-30 | $14k | 744 | 18.82 |
| 2022-03-31 | $10k | 744 | 13.44 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors